The California Governor wants to deny California subsidies to Tesla’s EVs.
Job losses from EV mandates are mounting across Europe.
Without effective and reliable international involvement, the Israel Defense Forces will end up back in Lebanon.
Rep. Seth Moulton says he’s getting credit for speaking freely. But he may face a primary challenge.
Republicans can update the Public Broadcasting Act to eliminate bias and improve local journalism.
Tradition and rivalries give the sport life. Fans worry that reform-minded executives don’t get it.
Justice’s Google case may finally bring home trustbusting’s irrelevance in today’s economy.
His biggest vote gains from 2020 came in states with the most immigrants. And he seems to have broken the Democratic monopoly on the black vote.
While posturing for coastal progressives, Gov. Newsom punishes Central Valley farmers and industry.
Federal arts and cultural organizations have spent decades funneling taxpayer dollars into projects ranging from the profane to the inane.
The Pentagon needs to modernize its plans to defend against new threats from Russia and China.
An independent agency of government shouldn’t have such enormous power to skew financial outcomes.
The company is losing $107,043 per EV sale, and taxpayers could end up paying.
Germans may finally get a chance to vote for economic growth.
His leadership and foresight still inspire the free world, 150 years after his birth.
The new U.K. government gets a lesson in supply-side economics as businesses revolt against tax hikes.
At the start of the FBI’s campaign against organized crime, few agents had any experience with guns or knew how to handle a crime scene.
Katori Hall’s play at Lincoln Center observes four daughters as they gather on an island off the coast of Georgia in the wake of their mother’s death.
The German painter and sculptor receives a retrospective in New York featuring more than 100 works, many of them bombastic and suffused with sarcasm.
Calling RFK Jr.: See the new treatment that will break a Pfizer monopoly on a drug for heart disease.
Pages